Capstone Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.1M | Buy |
2,235
+744
| +50% | +$404K | ﹤0.01% | 837 |
|
|
2025
Q4 | $864K | Sell |
1,491
-8,074
| -84% | -$4.57M | ﹤0.01% | 923 |
|
|
2025
Q3 | $4.64M | Sell |
9,565
-8,600
| -47% | -$4M | 0.01% | 493 |
|
|
2025
Q2 | $7.37M | Buy |
18,165
+7,848
| +76% | +$3.28M | 0.02% | 312 |
|
|
2025
Q1 | $5.13M | Sell |
10,317
-8,265
| -44% | -$4.48M | 0.01% | 441 |
|
|
2024
Q4 | $9.67M | Buy |
18,582
+18,480
| +18,118% | +$10.2M | 0.02% | 367 |
|
|
2024
Q3 | $63.1K | Sell |
102
-5,303
| -98% | -$3.14M | ﹤0.01% | 1777 |
|
|
2024
Q2 | $2.99M | Buy |
5,405
+5,084
| +1,584% | +$2.91M | 0.01% | 592 |
|
|
2024
Q1 | $187K | Sell |
321
-894
| -74% | -$502K | ﹤0.01% | 2030 |
|
|
2023
Q4 | $645K | Sell |
1,215
-18,662
| -94% | -$9.03M | ﹤0.01% | 1218 |
|
|
2023
Q3 | $10.1M | Buy |
19,877
+3,429
| +21% | +$1.83M | 0.05% | 272 |
|
|
2023
Q2 | $8.58M | Buy |
16,448
+13,551
| +468% | +$7.31M | 0.04% | 277 |
|
|
2023
Q1 | $1.67M | Sell |
2,897
-5,537
| -66% | -$3.12M | 0.01% | 644 |
|
|
2022
Q4 | $4.64M | Sell |
8,434
-7,979
| -49% | -$4.23M | 0.03% | 410 |
|
|
2022
Q3 | $8.32M | Buy |
16,413
+12,510
| +321% | +$7M | 0.05% | 266 |
|
|
2022
Q2 | $2.12M | Sell |
3,903
-92
| -2% | -$50.6K | 0.01% | 737 |
|
|
2022
Q1 | $2.36M | Buy |
3,995
+1,821
| +84% | +$1.05M | 0.01% | 984 |
|
|
2021
Q4 | $1.45M | Sell |
2,174
-17,868
| -89% | -$11.2M | ﹤0.01% | 1205 |
|
|
2021
Q3 | $11.5M | Buy |
20,042
+17,696
| +754% | +$9.71M | 0.02% | 577 |
|
|
2021
Q2 | $1.18M | Sell |
2,346
-30,555
| -93% | -$14.4M | ﹤0.01% | 1171 |
|
|
2021
Q1 | $15M | Buy |
+32,901
| New | +$15.7M | 0.04% | 363 |
|
|
2019
Q4 | – | Sell |
-6,633
| Closed | -$2.01M | – | 1457 |
|
|
2019
Q3 | $1.93M | Buy |
6,633
+2,910
| +78% | +$833K | 0.01% | 740 |
|
|
2019
Q2 | $1.09M | Buy |
+3,723
| New | +$1.03M | 0.01% | 914 |
|
|
2019
Q1 | – | Sell |
-1,032
| Closed | -$257K | – | 1372 |
|
|
2018
Q4 | $231K | Buy |
+1,032
| New | +$242K | ﹤0.01% | 1005 |
|
|
2018
Q3 | – | Sell |
-3,856
| Closed | -$887K | – | 1341 |
|
|
2018
Q2 | $799K | Buy |
+3,856
| New | +$818K | 0.01% | 421 |
|
|
2018
Q1 | – | Sell |
-1,100
| Closed | -$208K | – | 540 |
|
|
2017
Q4 | $208K | Buy |
+1,100
| New | +$211K | 0.01% | 431 |
|
|
2017
Q3 | – | Sell |
-38,560
| Closed | -$6.73M | – | 726 |
|
|
2017
Q2 | $6.73M | Sell |
38,560
-21,751
| -36% | -$3.65M | 0.18% | 101 |
|
|
2017
Q1 | $9.26M | Buy |
60,311
+14,055
| +30% | +$2.15M | 0.23% | 79 |
|
|
2016
Q4 | $6.53M | Buy |
46,256
+40,356
| +684% | +$5.95M | 0.2% | 98 |
|
|
2016
Q3 | $938K | Sell |
5,900
-2,100
| -26% | -$324K | 0.02% | 399 |
|
|
2016
Q2 | $1.18M | Buy |
+8,000
| New | +$1.18M | 0.02% | 316 |
|
|
2014
Q3 | – | Sell |
-3,900
| Closed | -$460K | – | 501 |
|
|
2014
Q2 | $460K | Buy |
+3,900
| New | +$459K | 0.01% | 356 |
|
Other funds holding TMO
VCM
Capstone Investment Advisors's TMO Position: Q1 2026 in Review
Capstone Investment Advisors increased its Thermo Fisher Scientific (TMO) stake by 50% in Q1 2026, buying an estimated $404K and bringing the position to 2,235 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #837.
Capstone Investment Advisors first reported a position in TMO in Q2 2014 and has held it in 32 quarters since. The position peaked at $15M in Q1 2021. 2,597 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Capstone Investment Advisors held 2,235 shares of Thermo Fisher Scientific worth $1.1M as of Q1 2026.
- Capstone Investment Advisors bought 744 Thermo Fisher Scientific shares in Q1 2026, an estimated $404K.
- Thermo Fisher Scientific made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #837 holding.
- Capstone Investment Advisors first reported a position in Thermo Fisher Scientific in Q2 2014 and has held it in 32 quarters since.
- Capstone Investment Advisors's Thermo Fisher Scientific position peaked at $15M in Q1 2021.
- 2,597 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.